Synovics Pharmaceuticals, Inc.
SYVC
$0.00
$0.000.00%
OTC PK
| 07/31/2009 | 04/30/2009 | 01/31/2009 | 10/31/2008 | 07/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -5.04M | -2.53M | -2.88M | -4.01M | -8.90M |
| Total Depreciation and Amortization | 674.20K | 612.70K | 619.40K | 611.40K | 666.10K |
| Total Amortization of Deferred Charges | 1.28M | 4.09M | 3.15M | 3.17M | 2.34M |
| Total Other Non-Cash Items | 1.49M | 2.46M | 4.89M | 4.52M | 6.23M |
| Change in Net Operating Assets | 3.59M | -263.40K | -2.13M | -427.10K | 1.93M |
| Cash from Operations | 1.99M | 4.37M | 3.64M | 3.86M | 2.27M |
| Capital Expenditure | -212.90K | -492.90K | -624.70K | -708.20K | -459.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 250.00K |
| Cash from Investing | -212.90K | -492.90K | -624.70K | -708.20K | -209.90K |
| Total Debt Issued | 1.25M | -119.50K | 1.30M | 1.30M | 4.76M |
| Total Debt Repaid | -4.12M | -10.48M | -11.10M | -11.19M | -14.14M |
| Issuance of Common Stock | 796.70K | 6.71M | 6.80M | 6.80M | 6.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -803.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.07M | -3.89M | -3.00M | -3.09M | -4.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -296.20K | -12.60K | 18.60K | 66.00K | -2.12M |